LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ibrutinib
Related studies linked through entity extraction aliases.
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
- Status
- COMPLETED
- Phase
- PHASE2
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4
- Status
- COMPLETED
- Phase
- PHASE1
Ibrutinib + Venetoclax in Untreated WM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ibrutinib and Rituxan for Chronic GVHD
- Status
- TERMINATED
- Phase
- PHASE2
Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)
- Status
- RECRUITING
- Phase
- PHASE2
Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice
- Status
- UNKNOWN
- Phase
- N/A
A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)
- Status
- COMPLETED
- Phase
- PHASE2
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)
- Status
- COMPLETED
- Phase
- PHASE4
Biomarker Guided Treatment in DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax
- Status
- TERMINATED
- Phase
- PHASE2